MktsMarkets

HCW Biologics Inc.
NASDAQ: HCWBKey statistics
HCWB News
Stories mentioning HCWB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6,500 | |||||||
| Cost of Goods Sold | 11.00 | 22.00 | 12.00 | 5.00 | 4.00 | 316.00 | 341.00 | 438.00 |
| Gross Profit | 6,532 | 6.00 | 3.00 | 1.00 | 1.00 | 79.00 | 85.00 | 180.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,258 | 1,333 | 1,404 | 1,227 | 1,479 | 1,050 | 1,187 | 2,029 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 3,296 | 4,446 | 3,295 | 3,465 | 1,967 | 3,222 | 3,770 | 15,316 |
| Operating Income (Loss) | 3,236 | (4,441) | (3,292) | (3,464) | (1,966) | (3,142) | (3,685) | (15,136) |
| Interest Income | ||||||||
| Interest Expense | 109.00 | 233.00 | 127.00 | 229.00 | 256.00 | 265.00 | 229.00 | 160.00 |
| Other Expense | ||||||||
| Pretax Income | 3,803 | (2,197) | ||||||
| Tax Provision | 330.00 | 0.00 | ||||||
| Net Income (Loss) | 3,472 | 719.00 | (4,554) | (1,928) | (2,197) | (3,374) | (3,902) | (15,280) |
| Earnings Per Share (Basic) | 0.37 | 0.34 | (2.02) | (6.79) | (1.97) | (3.48) | (4.13) | (16.16) |
| Earnings Per Share (Diluted) | 0.37 | 0.34 | (2.02) | (6.79) | (1.97) | (3.48) | (4.13) | (16.16) |
| Weighted Average Shares Outstanding (Basic) | 5,426 | 2,098 | 2,260 | 1,780 | 1,117 | 970.00 | 946.00 | 946.00 |
| Weighted Average Shares Outstanding (Diluted) | 5,426 | 2,098 | 2,260 | 1,780 | 1,117 | 970.00 | 946.00 | 946.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HCWB
HCW Biologics Inc. (NASDAQ: HCWB) is a stock listed on the Nasdaq Stock Market under the ticker symbol HCWB. It last traded at $1.06 (Nov 5, 2026, 11:23 AM ET), down 1.9% on the day. That gives HCW Biologics a market capitalisation of $2.4M.
Over the past 52 weeks HCWB has traded between $1.08 and $23.94.
Revenue for the quarter ended Mar 31, 2026 was $6.5M; net income $3.5M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $6.5M | $3.5M | 53.4% |
| Dec 31, 2025 | — | $719.0K | — |
| Sep 30, 2025 | — | -$4.6M | — |
| Jun 30, 2025 | — | -$1.9M | — |
From HCW Biologics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…